Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Azacitidine in lower-risk myelodysplastic syndromes.

    ... prolong overall survival (OS) compared with conventional care regimens in patients with higher-risk myelodysplastic syndromes ... rate (ORR) of 60% and a longer median OS compared with supportive care (44 vs 27 months). In a phase II study investigating ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.

    ... when analysis was restricted to 602 patients managed by supportive care . MK adversely affected survival in both poor and very poor karyotype ...

    Research Article last updated 06/20/2013 - 10:54am.

  3. How we treat lower risk myelodysplastic syndromes.

    ... mainly characterized by anemia in most cases. Supportive care , mainly red blood cell transfusions, remains an important ...

    Research Article last updated 05/14/2013 - 2:56pm.

  4. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study

    ... 189 AL-MDS patients. Ninety-four patients received best supportive care (BSC), and 94 patients received disease-modifying therapies (DMT) that ...

    Research Article last updated 04/02/2013 - 7:59am.

  5. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

    ... anemia (AA) are rare and data to guide standards of care are scarce. PROCEDURE: Eighteen pediatric institutions formed the ... if an HLA-identical sibling donor is not identified; supportive care measures; and slow taper of CSA after response. Areas of ...

    Research Article last updated 12/17/2013 - 8:30am.

  6. How I treat acquired aplastic anemia

    ... immunosuppressive biologics and drugs, and supportive care . However, management of SAA patients remains challenging, both acutely ...

    Research Article last updated 07/30/2012 - 2:00pm.

  7. A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

    ... trioxide (ATO). Twenty-two MDS patients receiving supportive care were used as controls. The remission was achieved in 4 patients ...

    Research Article last updated 06/15/2012 - 2:20pm.

  8. Treatment of myelodysplastic syndromes in elderly patients.

    ... the longest possible time. To achieve these objectives, supportive care is essential. Likewise, immunomodulatory drugs, such as ...

    Research Article last updated 02/10/2012 - 9:43am.

  9. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

    ... syndromes . Improvements in donor selection, supportive care and the introduction of reduced-intensity conditioning have led to a ...

    Research Article last updated 12/05/2011 - 10:23am.

  10. Management of aplastic anemia: the role of systematic reviews and meta-analyses.

    ... roles of alloHCT, IST, hematopoietic growth factors and supportive care . Bone Marrow Diseases:  ...

    Research Article last updated 10/11/2011 - 5:58pm.